Accelerate Diagnostics

About Accelerate Diagnostics

Accelerate Diagnostics, Inc. is an in vitro diagnostics company focused on tackling the global challenges of antibiotic resistance and sepsis. The company operates in the healthcare sector, providing advanced diagnostic solutions to hospitals and clinical laboratories. Its core product, the Accelerate Pheno® system, along with the Accelerate PhenoTest® BC kit, integrates multiple technologies to significantly reduce the time required for clinicians to determine the most effective antibiotic therapy for severe infections. The system automates the sample preparation process and delivers phenotypic antibiotic susceptibility results in approximately 7 hours directly from positive blood cultures. This rapid turnaround is 1–2 days faster than traditional methods, allowing healthcare providers to optimize antibiotic selection and dosage much earlier, which can be critical for patient outcomes. Accelerate Diagnostics generates revenue through the sale of its diagnostic systems and test kits, primarily targeting healthcare institutions that require efficient and accurate diagnostic tools to manage infectious diseases.